Courage Therapeutics
PrivateLast Round
Seed
Nov 3, 2025
Total Funding Raised
$19.04M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Courage Therapeutics is a biotechnology company that develops small molecule and peptide therapeutics targeting melanocortin receptors to treat obesity and restrictive eating disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Courage Therapeutics Comparables
Compare Courage Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kalohexis | 86% | |
| Gazella Biotech | 72% | |
| Palatin Technologies | 71% |
Courage Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 3, 2025 | ||||
| Seed | May 16, 2025 | ||||
| Grant | Apr 22, 2021 | ||||
| Seed | Mar 24, 2021 |
Courage Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Mental Health | Grant |
| NIH RADx | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Arsenal Bridge Ventures | Seed |
| MIT Alumni Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2025
$10M round led by Arsenal Bridge Ventures
- May 16, 2025
$7.8M round completed.
Courage Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Courage Therapeutics's valuation, stock price, and market status.
Is Courage Therapeutics a public or private company?
Courage Therapeutics is a private company.
What is the current stock price of Courage Therapeutics?
Courage Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Courage Therapeutics worth (valuation)?
Valuation information for Courage Therapeutics is not publicly available.
Can I buy Courage Therapeutics stock?
Courage Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Courage Therapeutics's last funding round?
Courage Therapeutics's most recent funding round was Seed on November 3, 2025.
Who are the main investors in Courage Therapeutics?
Key investors in Courage Therapeutics include Arsenal Bridge Ventures.
Will Courage Therapeutics IPO soon?
No public IPO plans have been announced for Courage Therapeutics.
How can I track Courage Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Courage Therapeutics's secondary market activity and sign up for updates.